Concepedia

Alfonso Lopez

AL

Statistics

Publications

1

Citations

94

H-Index

1

Active since

2023

Affiliations

Mateon Therapeutics (United States)(Current)

Alfonso Lopez is an author at Mateon Therapeutics (United States).

ORCID

Publications per year

2023–2023

1

Publications

1

Genome-Wide CRISPR Screens Identify Multiple Synthetic Lethal Targets That Enhance KRASG12C Inhibitor Efficacy

Suman Mukhopadhyay, Hsin‐Yi Huang, Ziyan Lin et al. · Cancer Research · 2023 · 94 citations · Full text

Rows per page

1–1 of 1